Results 151 to 160 of about 764,021 (214)

The effects of coconut oil intake on metabolic disorders and fatty liver disease in mice. [PDF]

J Nutr Sci
Sumi M, Hasegawa Y, Matsuyama T, Miyoshi T, Nakajima H, Okamura T, Nakanishi N, Sasano R, Hamaguchi M, Fukui M.   +9 more
europepmc   +1 more source

Effects of a combination of puerarin, baicalin and berberine on the expression of proliferator-activated receptor-γ and insulin receptor in a rat model of nonalcoholic fatty liver disease

, 2015
Weihan Zhao, Lijuan Liu, Yunliang Wang, Tangyou Mao, Junxiang Li   +4 more
openalex   +2 more sources

Diet and Lifestyle Interventions in Metabolic Dysfunction-Associated Fatty Liver Disease: A Comprehensive Review. [PDF]

Int J Mol Sci
Sheikh MY, Younus MF, Shergill A, Hasan MN.   +3 more
europepmc   +1 more source

Curcumin's dual effect on pyroptosis and autophagy in metabolic- associated fatty liver disease: a potential therapeutic strategy. [PDF]

Sci Rep
Eldken ZH, Youssef OM, Khalil RM, Kassab AAM, Ramadan A, Sakr NH.   +5 more
europepmc   +1 more source

National Protect Liver Day 2025 in China: Integrating Traditional Chinese Medicine and Western Medicine to Reverse Liver Cirrhosis

Liver Research
Cuicui Shi, Jiangao Fan
doaj   +1 more source

Characterization of the gut mycobiome in patients with non-alcoholic fatty liver disease and correlations with serum metabolome. [PDF]

BMC Microbiol
Zheng N, Wang D, Xing G, Gao Y, Li S, Liu J, Kang J, Sha S, Cheng L, Fan S, Yu J, Yan Q, Jiang C.   +12 more
europepmc   +1 more source

Synovial sarcoma extracellular vesicles induce fatty liver. [PDF]

Biophys Rep
Ren T, Zhou Z, Hong H, Cen B, Xiao J, Chen G, Zhang Y, Li J.   +7 more
europepmc   +1 more source

Role of metabolic dysfunction-associated fatty liver disease in atrial fibrillation and heart failure: molecular and clinical aspects [PDF]

Jamie Cheung, Bernard M.Y. Cheung, Kai‐Hang Yiu, Hung‐Fat Tse, Yap‐Hang Chan   +4 more
openalex   +1 more source

<i>PLIN5</i> deficiency ameliorates metabolic dysfunction‑associated fatty liver disease by inhibiting ferroptosis. [PDF]

Mol Med Rep
Li Y, Wang X, Yin X, Zhu X, Cui W, Dong L, Xia Y, Wang Y, Liu L, Zheng P, Tang Y.   +10 more
europepmc   +1 more source

Intracellular cholesterol transporters and modulation of hepatic lipid metabolism: implications for diabetic dyslipidaemia and steatosis [PDF]

, 2014
Caridis, Anna-Maria, Dolan, Sharron, Graham, Annette, Soffientini, Ugo   +3 more
core   +1 more source